Waiting is no longer an option for household contacts of people with drug-resistant tuberculosis

Lancet Infect Dis. 2024 Sep;24(9):947-949. doi: 10.1016/S1473-3099(24)00233-0.

Authors

Jean Pannikottu¹, Anja Reuter², Elize Pietersen³, Goodman Makhanda⁴, Johnny Daniels², Busisiwe Beko², Ivy Apolisi², Jennifer Furin⁵

Affiliations

¹ University Hospitals Cleveland Medical Center, Division of Infectious Diseases and HIV Medicine, Cleveland, OH, USA.
² The Sentinel Project on Pediatric Drug-Resistant Tuberculosis, Cape Town, South Africa.
³ Free of TB, Cape Town, South Africa.
⁴ TB Proof, Cape Town, South Africa.
⁵ Harvard Medical School Department of Global Health and Social Medicine, Boston, MA 02115, USA. Electronic address: jennifer_furin@hms.harvard.edu.

PMID: 39179340
DOI: 10.1016/S1473-3099(24)00233-0

No abstract available

MeSH terms

Antitubercular Agents / therapeutic use
Contact Tracing*
Family Characteristics*
Humans
Tuberculosis, Multidrug-Resistant* / drug therapy
Tuberculosis, Multidrug-Resistant* / epidemiology

Substances

Antitubercular Agents